Targeting tumor cell motility to prevent metastasis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Mortality and morbidity in patients with solid tumors invariably results from the disruption of normal biological function caused by disseminating tumor cells. Tumor cell migration is under intense investigation as the underlying cause of cancer metastasis. The need for tumor cell motility in the progression of metastasis has been established experimentally and is supported empirically by basic and clinical research implicating a large collection of migration-related genes. However, there are few clinical interventions designed to specifically target the motility of tumor cells and adjuvant therapy to specifically prevent cancer cell dissemination is severely limited. In an attempt to define motility targets suitable for treating metastasis, we have parsed the molecular determinants of tumor cell motility into five underlying principles including cell autonomous ability, soluble communication, cell-cell adhesion, cell-matrix adhesion, and integrating these determinants of migration on molecular scaffolds. The current challenge is to implement meaningful and sustainable inhibition of metastasis by developing clinically viable disruption of molecular targets that control these fundamental capabilities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196 · cited 6×
“The latter can be acquired through a transient epigenetic plasticity such as the epithelial-mesenchymal transition (EMT) [18, 19] or an evolutionary selection of epigenetic and genetic changes [20].”
BackgroundInfluentialThe distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 7×
“Systemic dissemination requires that tumor cells access the vasculature and travel via the circulatory system to a distant site where the cells extravasate and establish secondary tumor growth (reviewed comprehensively by Weiss [22] and Fidler [14]).”
BackgroundInfluentialMesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Phenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613 · cited 6×
“The latter can be acquired through a transient epigenetic plasticity such as the epithelial-mesenchymal transition (EMT) [18, 19] or an evolutionary selection of epigenetic and genetic changes [20].”
BackgroundInfluentialGaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 1×
“CAF promote tumor cell motility through the induced expression of paracrine acting cytokines and by physically encouraging the invasion of tumor cells [69].”
Background
Cited by
KHOURY, N., EL-HAYEK, S., TARRAS, O., EL-SABBAN, M., EL-SIBAI, M., & RIZK, S. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2635 · Cited by 77
“Since metastasis remains the main cause of death in cancer patients, we assessed the effect of cell‐free fractions of kefir on the motility of crc cells in vitro (29).”
BackgroundKpetemey, M., Dasgupta, S., Rajendiran, S., Das, S., Gibbs, L. D., Shetty, P., Gryczynski, Z., & Vishwanatha, J. K. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0428-8 · Cited by 68
“The onset of metastasis depends primarily on the ability of tumor cells to detach from basement membranes by cleaving extracellular matrix proteins and promoting motility and invasion to propel forward [7–11].”
BackgroundAnticancer Effects of Colchicine on Hypopharyngeal Cancer
(2017) · Anticancer Research · doi:10.21873/anticanres.12078 · Cited by 17
Metadata
- Authors
- Palmer, T. D., Ashby, W. J., Lewis, J. D., & Zijlstra, A.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2011-07
- Volume
- 63
- Issue
- 8
- Pages
- 568-581
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2018295362
- Cited by
- 173
- References
- 17
- FWCI
- 0.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting tumor cell motility to prevent metastasis. https://app.cochat.ai/papers/10.1016/j.addr.2011.04.008
- The paper
- Palmer, T. D., Ashby, W. J., Lewis, J. D., & Zijlstra, A. (2011). Targeting tumor cell motility to prevent metastasis. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2011.04.008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.